Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000120715 | SCV000228959 | likely benign | not specified | 2015-01-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000120715 | SCV000247299 | benign | not specified | 2019-04-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002517584 | SCV000770218 | benign | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001530014 | SCV001846823 | benign | not provided | 2019-01-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30132219, 17299436) |
Ce |
RCV001530014 | SCV004147983 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | EP300: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV001530014 | SCV005206511 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000120715 | SCV000084877 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Diagnostic Laboratory, |
RCV001530014 | SCV001744499 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001530014 | SCV001798298 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935150 | SCV004748293 | benign | EP300-related disorder | 2019-04-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |